Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPVHIB | DTAP + IPV + HIB (PENTACEL) | SANOFI PASTEUR | UNK | UK167AA | — |
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 3 | — | LL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y007615 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y011020 | — |
inadvertently reconstituted both the MMR II and VARIVAX Vaccines with the VAXELIS Vaccine instead of the STERILE DILUENT. The patient received both vaccines on the same day on 01/27/2025.; Vaccines with the VAXELIS Vaccine instead of the STERILE DILUENT. Pentacel vaccine administered the same day; inadvertently reconstituted both the MMR II and VARIVAX Vaccines with the VAXELIS Vaccine instead of the STERILE DILUENT. The patient received both vaccines on the same day on 01/27/2025.; This non-serious, spontaneous, safety report was received by partner on 30-JAN-2025 and forwarded to agency on 30-JAN-2025 from a healthcare professional. Due to the nature of the event, the causality between the event "inadvertently reconstituted both the MMR II and VARIVAX Vaccines with the VAXELIS Vaccine instead of the STERILE DILUENT. The patient received both vaccines on the same day on 01/27/2025" and Vaxelis was not applicable. Further information is expected Significant follow-up information was received by the partner on 13-FEB-2025 and forwarded to agency on 13-FEB-2025, from other health professional. The case is maintained as non-serious. Due to the nature of the event, the causality between the event "inadvertently reconstituted both the MMR II and VARIVAX Vaccines with the VAXELIS Vaccine instead of the STERILE DILUENT. The patient received both vaccines on the same day on 01/27/2025" and Vaxelis was not applicable. Further information is not expected.
Prophylaxis